Press release
Global and United States Gynecological Cancer Diagnostics Market Report & Forecast 2022-2028
This report focuses on global and United States Gynecological Cancer Diagnostics market, also covers the segmentation data of other regions in regional level and county level.Global Gynecological Cancer Diagnostics Scope and Market Size
Gynecological Cancer Diagnostics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Gynecological Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Gynecological Cancer Diagnostics market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Genetic Counseling Test
Cancer Risk Test
Kits Test
Segment by Application
Gestational Trophoblastic Disease Diagnostics
Endometrial Cancer Diagnostics
Peritoneal Cancer Diagnostics
Cervical Cancer Diagnostics
Ovarian Cancer Diagnostics
Vaginal Cancer Diagnostics
Uterine Cancer Diagnostics
Vulvar Cancer Diagnostics
By Company
UT Southwestern
Abramson Cancer Center
Northwestern Medicine
Sysmex Europe SE
Fujirebio
Premier Health
Agilent Technologies, Inc
ARUP Laboratories
CENTOGENE
F. Hoffmann-La Roche Ltd
Fulgent Genetics, Inc
Invitae Corporation
Myriad Genetics, Inc
BGI Group
Research objectives
1. To study and analyze the global Gynecological Cancer Diagnostics consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
2. To understand the structure of Gynecological Cancer Diagnostics market by identifying its various subsegments.
3. Focuses on the key global Gynecological Cancer Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
4. To analyze the Gynecological Cancer Diagnostics with respect to individual growth trends, prospects, and their contribution to the total market.
5. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
6. To project the consumption of Gynecological Cancer Diagnostics submarkets, with respect to key regions (along with their respective key countries).
7. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8. To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Study Coverage
1.1 Gynecological Cancer Diagnostics Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Gynecological Cancer Diagnostics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Gynecological Cancer Diagnostics Market Size for the Year 2017-2028
1.2.2 Global Gynecological Cancer Diagnostics Market Size for the Year 2017-2028
1.3 Gynecological Cancer Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Gynecological Cancer Diagnostics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Gynecological Cancer Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Gynecological Cancer Diagnostics Market Dynamics
1.4.1 Gynecological Cancer Diagnostics Industry Trends
1.4.2 Gynecological Cancer Diagnostics Market Drivers
1.4.3 Gynecological Cancer Diagnostics Market Challenges
1.4.4 Gynecological Cancer Diagnostics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Gynecological Cancer Diagnostics by Type
2.1 Gynecological Cancer Diagnostics Market Segment by Type
2.1.1 Genetic Counseling Test
2.1.2 Cancer Risk Test
2.1.3 Kits Test
2.2 Global Gynecological Cancer Diagnostics Market Size by Type (2017, 2022 & 2028)
2.3 Global Gynecological Cancer Diagnostics Market Size by Type (2017-2028)
2.4 United States Gynecological Cancer Diagnostics Market Size by Type (2017, 2022 & 2028)
2.5 United States Gynecological Cancer Diagnostics Market Size by Type (2017-2028)
3 Gynecological Cancer Diagnostics by Application
3.1 Gynecological Cancer Diagnostics Market Segment by Application
3.1.1 Gestational Trophoblastic Disease Diagnostics
3.1.2 Endometrial Cancer Diagnostics
3.1.3 Peritoneal Cancer Diagnostics
3.1.4 Cervical Cancer Diagnostics
3.1.5 Ovarian Cancer Diagnostics
3.1.6 Vaginal Cancer Diagnostics
3.1.7 Uterine Cancer Diagnostics
3.1.8 Vulvar Cancer Diagnostics
3.2 Global Gynecological Cancer Diagnostics Market Size by Application (2017, 2022 & 2028)
3.3 Global Gynecological Cancer Diagnostics Market Size by Application (2017-2028)
3.4 United States Gynecological Cancer Diagnostics Market Size by Application (2017, 2022 & 2028)
3.5 United States Gynecological Cancer Diagnostics Market Size by Application (2017-2028)
4 Global Gynecological Cancer Diagnostics Competitor Landscape by Company
4.1 Global Gynecological Cancer Diagnostics Market Size by Company
4.1.1 Top Global Gynecological Cancer Diagnostics Companies Ranked by Revenue (2021)
4.1.2 Global Gynecological Cancer Diagnostics Revenue by Player (2017-2022)
4.2 Global Gynecological Cancer Diagnostics Concentration Ratio (CR)
4.2.1 Gynecological Cancer Diagnostics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Gynecological Cancer Diagnostics in 2021
4.2.3 Global Gynecological Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Gynecological Cancer Diagnostics Headquarters, Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Gynecological Cancer Diagnostics Headquarters and Area Served
4.3.2 Global Gynecological Cancer Diagnostics Companies Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Gynecological Cancer Diagnostics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Gynecological Cancer Diagnostics Market Size by Company
4.5.1 Top Gynecological Cancer Diagnostics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Gynecological Cancer Diagnostics Revenue by Players (2020, 2021 & 2022)
5 Global Gynecological Cancer Diagnostics Market Size by Region
5.1 Global Gynecological Cancer Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Gynecological Cancer Diagnostics Market Size by Region (2017-2028)
5.2.1 Global Gynecological Cancer Diagnostics Market Size by Region: 2017-2022
5.2.2 Global Gynecological Cancer Diagnostics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Gynecological Cancer Diagnostics Market Size YoY Growth 2017-2028
6.1.2 North America Gynecological Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Gynecological Cancer Diagnostics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Gynecological Cancer Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Gynecological Cancer Diagnostics Market Size YoY Growth 2017-2028
6.3.2 Europe Gynecological Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Gynecological Cancer Diagnostics Market Size YoY Growth 2017-2028
6.4.2 Latin America Gynecological Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Gynecological Cancer Diagnostics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Gynecological Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 UT Southwestern
7.1.1 UT Southwestern Company Details
7.1.2 UT Southwestern Business Overview
7.1.3 UT Southwestern Gynecological Cancer Diagnostics Introduction
7.1.4 UT Southwestern Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
7.1.5 UT Southwestern Recent Development
7.2 Abramson Cancer Center
7.2.1 Abramson Cancer Center Company Details
7.2.2 Abramson Cancer Center Business Overview
7.2.3 Abramson Cancer Center Gynecological Cancer Diagnostics Introduction
7.2.4 Abramson Cancer Center Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
7.2.5 Abramson Cancer Center Recent Development
7.3 Northwestern Medicine
7.3.1 Northwestern Medicine Company Details
7.3.2 Northwestern Medicine Business Overview
7.3.3 Northwestern Medicine Gynecological Cancer Diagnostics Introduction
7.3.4 Northwestern Medicine Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
7.3.5 Northwestern Medicine Recent Development
7.4 Sysmex Europe SE
7.4.1 Sysmex Europe SE Company Details
7.4.2 Sysmex Europe SE Business Overview
7.4.3 Sysmex Europe SE Gynecological Cancer Diagnostics Introduction
7.4.4 Sysmex Europe SE Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
7.4.5 Sysmex Europe SE Recent Development
7.5 Fujirebio
7.5.1 Fujirebio Company Details
7.5.2 Fujirebio Business Overview
7.5.3 Fujirebio Gynecological Cancer Diagnostics Introduction
7.5.4 Fujirebio Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
7.5.5 Fujirebio Recent Development
7.6 Premier Health
7.6.1 Premier Health Company Details
7.6.2 Premier Health Business Overview
7.6.3 Premier Health Gynecological Cancer Diagnostics Introduction
7.6.4 Premier Health Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
7.6.5 Premier Health Recent Development
7.7 Agilent Technologies, Inc
7.7.1 Agilent Technologies, Inc Company Details
7.7.2 Agilent Technologies, Inc Business Overview
7.7.3 Agilent Technologies, Inc Gynecological Cancer Diagnostics Introduction
7.7.4 Agilent Technologies, Inc Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
7.7.5 Agilent Technologies, Inc Recent Development
7.8 ARUP Laboratories
7.8.1 ARUP Laboratories Company Details
7.8.2 ARUP Laboratories Business Overview
7.8.3 ARUP Laboratories Gynecological Cancer Diagnostics Introduction
7.8.4 ARUP Laboratories Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
7.8.5 ARUP Laboratories Recent Development
7.9 CENTOGENE
7.9.1 CENTOGENE Company Details
7.9.2 CENTOGENE Business Overview
7.9.3 CENTOGENE Gynecological Cancer Diagnostics Introduction
7.9.4 CENTOGENE Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
7.9.5 CENTOGENE Recent Development
7.10 F. Hoffmann-La Roche Ltd
7.10.1 F. Hoffmann-La Roche Ltd Company Details
7.10.2 F. Hoffmann-La Roche Ltd Business Overview
7.10.3 F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Introduction
7.10.4 F. Hoffmann-La Roche Ltd Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
7.10.5 F. Hoffmann-La Roche Ltd Recent Development
7.11 Fulgent Genetics, Inc
7.11.1 Fulgent Genetics, Inc Company Details
7.11.2 Fulgent Genetics, Inc Business Overview
7.11.3 Fulgent Genetics, Inc Gynecological Cancer Diagnostics Introduction
7.11.4 Fulgent Genetics, Inc Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
7.11.5 Fulgent Genetics, Inc Recent Development
7.12 Invitae Corporation
7.12.1 Invitae Corporation Company Details
7.12.2 Invitae Corporation Business Overview
7.12.3 Invitae Corporation Gynecological Cancer Diagnostics Introduction
7.12.4 Invitae Corporation Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
7.12.5 Invitae Corporation Recent Development
7.13 Myriad Genetics, Inc
7.13.1 Myriad Genetics, Inc Company Details
7.13.2 Myriad Genetics, Inc Business Overview
7.13.3 Myriad Genetics, Inc Gynecological Cancer Diagnostics Introduction
7.13.4 Myriad Genetics, Inc Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
7.13.5 Myriad Genetics, Inc Recent Development
7.14 BGI Group
7.14.1 BGI Group Company Details
7.14.2 BGI Group Business Overview
7.14.3 BGI Group Gynecological Cancer Diagnostics Introduction
7.14.4 BGI Group Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
7.14.5 BGI Group Recent Development
8 Research Findings and Conclusion
9 Appendix
If you would like to get a FREE sample, place an order, or have any questions, please enter
https://us.qyresearch.com/reports/347276/gynecological-cancer-diagnostics
Any doubts and questions will be welcome
About Us:
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com
This report focuses on global and United States Gynecological Cancer Diagnostics market, also covers the segmentation data of other regions in regional level and county level.
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global and United States Gynecological Cancer Diagnostics Market Report & Forecast 2022-2028 here
News-ID: 2597068 • Views: …
More Releases from QY Research
Global and U.S. Car Exhaust Emission Analyzers Market Report, Published by QY Re …
QY Research has released a comprehensive new market report on Car Exhaust Emission Analyzers, are instruments used to measure and monitor the pollutants emitted from internal combustion engines, including carbon monoxide (CO), carbon dioxide (CO2), hydrocarbons (HC), nitrogen oxides (NOx), and oxygen (O2). They are essential for vehicle emissions testing, regulatory compliance, engine tuning, and environmental monitoring.
https://www.qyresearch.com/reports/5536960/car-exhaust-emission-analyzers
Core Market Data
Global market size: USD 1.0 billion
CAGR (2024-2030): 5.3%
Average price: USD 4000 per…
How Temperature-Responsive Polymers Are Transforming Precision Drug Delivery
A biomedical materials company significantly improved drug-delivery precision and process efficiency after integrating Temperature-Responsive Polymers into its controlled-release formulation platform. These smart polymers-also known as thermoresponsive polymers-exhibit a reversible phase transition at a defined critical temperature (LCST or UCST), enabling predictable changes in solubility, permeability, or mechanical behavior in response to temperature variation. Materials such as poly(N-isopropylacrylamide) (PNIPAM) and its copolymers are widely used to enable on-demand drug release, cell…
Global and U.S. Resistive Strain Gauge Sensors Market Report, Published by QY Re …
QY Research has released a comprehensive new market report on Resistive Strain Gauge Sensors, precision sensing elements that convert mechanical deformation into measurable electrical resistance changes. As foundational components in force, load, pressure, and torque measurement systems, resistive strain gauges are widely used across industrial automation, civil infrastructure monitoring, aerospace testing, automotive validation, and scientific research. With rising demand for high-accuracy structural monitoring, lightweight sensing solutions, and reliable long-term measurement…
Top 30 Indonesian Public Manufacturing Companies Q3 2025 Revenue & Performance
1) Overall companies performance (Q3 2025 snapshot)
Q3-2025 showed a mixed recovery across Indonesian manufacturing subsectors:
Auto & heavy equipment: improving vehicle sales & financing activity helped conglomerates with auto exposure (Astra) and heavy-equipment vendors, though some mining/commodity segments weighed on margins.
Consumer staples & FMCG: food processors and household goods makers (Indofood, Unilever Indonesia, Kalbe) were broadly resilient domestic demand and agribusiness price pass-through helped toplines.
Petrochemicals: Chandra Asri reported very strong revenue…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
